Your browser doesn't support javascript.
loading
Synthesis of HDAC Inhibitor Libraries via Microscale Workflow.
Dykstra, Kevin D; Streckfuss, Eric; Liu, Min; Liu, Jian; Yu, Younong; Wang, Ming; Kozlowski, Joseph A; Myers, Robert W; Buevich, Alexei V; Maletic, Milana M; Vachal, Petr; Krska, Shane W.
Afiliação
  • Dykstra KD; Chemical Capabilities for Accelerating Therapeutics, Merck & Co., Inc., Kenilworth, New Jersey 07033, United States.
  • Streckfuss E; Discovery Chemistry, Merck & Co., Inc., West Point, Pennsylvania 19486, United States.
  • Liu M; Chemical Capabilities for Accelerating Therapeutics, Merck & Co., Inc., Kenilworth, New Jersey 07033, United States.
  • Liu J; Screening, Targets and Compound Profiling, Merck & Co., Inc., Kenilworth, New Jersey 07033, United States.
  • Yu Y; Chemical Capabilities for Accelerating Therapeutics, Merck & Co., Inc., Kenilworth, New Jersey 07033, United States.
  • Wang M; Chemical Capabilities for Accelerating Therapeutics, Merck & Co., Inc., Kenilworth, New Jersey 07033, United States.
  • Kozlowski JA; Discovery Chemistry, Merck & Co., Inc., Kenilworth, New Jersey 07033, United States.
  • Myers RW; Pharmacokinetics, Pharmacodynamics and Drug Metabolism, Merck & Co., Inc., Kenilworth, New Jersey 07033, United States.
  • Buevich AV; NMR Structure Elucidation, Merck & Co., Inc., Kenilworth, New Jersey 07033, United States.
  • Maletic MM; Chemical Capabilities for Accelerating Therapeutics, Merck & Co., Inc., Kenilworth, New Jersey 07033, United States.
  • Vachal P; Screening, Targets and Compound Profiling, Merck & Co., Inc., Kenilworth, New Jersey 07033, United States.
  • Krska SW; Chemical Capabilities for Accelerating Therapeutics, Merck & Co., Inc., Kenilworth, New Jersey 07033, United States.
ACS Med Chem Lett ; 12(3): 337-342, 2021 Mar 11.
Article em En | MEDLINE | ID: mdl-33738059
An integrated workflow has been established that enables the synthesis, purification, and subsequent biological testing of compound libraries on a microgram scale. This approach utilizes mass directed preparative HPLC in conjunction with charged aerosol detection (CAD) to generate solutions of investigational compounds at high purity and standardized concentrations, facilitating high fidelity biological testing. This new workflow successfully delivered libraries of histone deacetylase (HDAC) inhibitors that afforded biological data consistent with that obtained from standard scale parallel medicinal chemistry techniques. The advantages of this new approach to library synthesis include greatly reduced material requirements and amenability to high-throughput experimentation.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: ACS Med Chem Lett Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: ACS Med Chem Lett Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
...